Results 11 to 20 of about 3,936,691 (310)

Psoriasis and Connective Tissue Diseases [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Psoriasis is a chronic systemic inflammatory disease with various co-morbidities, having been recently considered as a comprehensive disease named psoriatic disease or psoriatic syndrome. Autoimmune diseases are one form of its co-morbidities. In addition to the genetic background, shared pathogenesis including innate immunity, neutrophil extracellular
Toshiyuki Yamamoto
openaire   +3 more sources

The significance of prolactin in systemic connective tissue diseases

open access: yes, 2023
Objectives Does prolactin (PRL) level testing in the diagnosis of systemic connective tissue diseases make sense and should we test it in everyday practice?
Michał Piotr Jakubaszek
core   +1 more source

Efficacy of Nigella sativa seeds oil in patients with Behcet’s disease: a double-blind randomized controlled trial [PDF]

open access: yesAvicenna Journal of Phytomedicine, 2018
Objective: Nigella sativa (NS) is a herbal medicine with anti-inflammatory and anti-oxidant functions. This study was designed to evaluate the effect of oral administration of NS seeds oil on the treatment of Behcet’s disease (BD).
Hadiseh Kavandi   +2 more
doaj   +1 more source

Biomarkers in connective tissue diseases [PDF]

open access: yesJournal of Allergy and Clinical Immunology, 2017
Autoimmune connective tissue diseases are clinically variable, making biomarkers desirable for assessing future disease risk, supporting early and accurate diagnosis, monitoring disease activity and progression, selecting therapeutics, and assessing treatment response.
Neelakshi R, Jog, Judith A, James
openaire   +2 more sources

Comparison of International Study Group Criteria and International Criteria for Behcet's Disease in the Azeri population of Iran [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2017
Introduction: Behcet's disease (BD) is a chronic systemic inflammatory disease affecting multiple organs and systems such as mucosa, skin, eye, joints and cardiovascular, nervous and gastrointestinal systems. Various criteria are proposed for
Leila Delnabi   +4 more
doaj   +1 more source

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients [PDF]

open access: yes, 2001
Patients with scleroderma receiving Iloprost as a treatment for severe Raynaud's phenomenon report a reduction in skin tightness, suggesting that this drug inhibits skin fibrosis.
Stratton, R   +17 more
core   +1 more source

Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells [PDF]

open access: yes, 2007
Mesangial cells are thought to be important mediators of glomerular inflammation and fibrosis. Studies have established a direct role for nitric oxide (NO) in the regulation of gene expression in mesangial cells.
Nelson, Peter J.   +4 more
core   +1 more source

Connective tissue disease in pregnancy [PDF]

open access: yesClinical Medicine, 2013
Connective tissue diseases (CTD) include a variety of chronic multisystem disorders with a high percentage of autoimmune conditions. Many of these conditions affect women of childbearing age and, therefore, pregnancy poses an important challenge for doctors looking after such women.
Ateka-Barrutia, Oier   +1 more
openaire   +3 more sources

Microangiopathic antiphospholipid syndrome (MAPS) in the course of undifferentiated connective tissue disease

open access: yesJournal of Medical Science, 2014
Introduction. The microangiopathic antiphospholipid syndrome (MAPS) is a subset of APS comprising those patients presenting with thrombotic microangiopathy and demonstrable antiphospholipid antibodies. Renal involvement occurs frequently in the course of
Bożena Targońska-Stępniak   +2 more
doaj   +1 more source

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis

open access: yesFrontiers in Immunology, 2022
BackgroundRecent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that ‘metabolic reprogramming’ involving the glycolysis and oxidative phosphorylation ...
Isabella Gomes Cantanhede   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy